These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30640573)

  • 1. Effects of ketamine use on psychotic disorders and symptoms in male, methamphetamine-dependent subjects.
    Dong H; Yang C; Shen Y; Liu L; Liu M; Hao W
    Am J Drug Alcohol Abuse; 2019; 45(3):276-284. PubMed ID: 30640573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
    McKetin R; Baker AL; Dawe S; Voce A; Lubman DI
    Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine.
    McKetin R; Hides L; Kavanagh DJ; Saunders JB; Dawe S
    Schizophr Res; 2018 Sep; 199():456-457. PubMed ID: 29680188
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.
    McKetin R; Lubman DI; Baker AL; Dawe S; Ali RL
    JAMA Psychiatry; 2013 Mar; 70(3):319-24. PubMed ID: 23303471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants.
    Mahoney JJ; Hawkins RY; De La Garza R; Kalechstein AD; Newton TF
    Gend Med; 2010 Oct; 7(5):414-21. PubMed ID: 21056868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.
    Alexander PD; Gicas KM; Willi TS; Kim CN; Boyeva V; Procyshyn RM; Smith GN; Thornton AE; Panenka WJ; Jones AA; Vila-Rodriguez F; Lang DJ; William MacEwan G; Honer WG; Barr AM
    Psychopharmacology (Berl); 2017 May; 234(9-10):1535-1547. PubMed ID: 28190084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia.
    Sulaiman AH; Said MA; Habil MH; Rashid R; Siddiq A; Guan NC; Midin M; Nik Jaafar NR; Sidi H; Das S
    Compr Psychiatry; 2014 Jan; 55 Suppl 1():S89-94. PubMed ID: 23433219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotic symptoms in methamphetamine psychotic in-patients.
    Srisurapanont M; Ali R; Marsden J; Sunga A; Wada K; Monteiro M
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):347-52. PubMed ID: 14604449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders.
    Temmingh HS; van den Brink W; Howells F; Sibeko G; Stein DJ
    J Dual Diagn; 2020; 16(2):208-217. PubMed ID: 31984872
    [No Abstract]   [Full Text] [Related]  

  • 10. Typologies of positive psychotic symptoms in methamphetamine dependence.
    Bousman CA; McKetin R; Burns R; Woods SP; Morgan EE; Atkinson JH; Everall IP; Grant I;
    Am J Addict; 2015 Mar; 24(2):94-97. PubMed ID: 25864598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a discrete negative symptom syndrome in people who use methamphetamine?
    Voce A; Burns R; Castle D; Calabria B; McKetin R
    Compr Psychiatry; 2019 Aug; 93():27-32. PubMed ID: 31301605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users.
    McKetin R; Gardner J; Baker AL; Dawe S; Ali R; Voce A; Leach LS; Lubman DI
    Psychiatry Res; 2016 Apr; 238():166-171. PubMed ID: 27086229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting severity of positive and negative symptoms of psychosis in a polysubstance using population with psychostimulant dependence.
    Willi TS; Honer WG; Thornton AE; Gicas K; Procyshyn RM; Vila-Rodriguez F; Panenka WJ; Aleksic A; Leonova O; Jones AA; MacEwan GW; Barr AM
    Psychiatry Res; 2016 Jun; 240():336-342. PubMed ID: 27138828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participants.
    Mahoney JJ; Kalechstein AD; De La Garza R; Newton TF
    Am J Addict; 2008; 17(2):83-98. PubMed ID: 18393050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users.
    Lapworth K; Dawe S; Davis P; Kavanagh D; Young R; Saunders J
    Addict Behav; 2009 Apr; 34(4):380-5. PubMed ID: 19097704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature.
    Grelotti DJ; Kanayama G; Pope HG
    Am J Psychiatry; 2010 Jan; 167(1):17-23. PubMed ID: 20068123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of psychotic symptoms among methamphetamine users.
    McKetin R; McLaren J; Lubman DI; Hides L
    Addiction; 2006 Oct; 101(10):1473-8. PubMed ID: 16968349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China.
    Zhang Y; Lu C; Zhang J; Hu L; Song H; Li J; Kang L
    Addict Behav; 2013 Jan; 38(1):1424-30. PubMed ID: 23006246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring the prevalence of methamphetamine-related presentations at psychiatric hospitals in Cape Town, South Africa.
    Plüddemann A; Dada S; Parry CD; Kader R; Parker JS; Temmingh H; van Heerden S; de Clercq C; Lewis I
    Afr J Psychiatry (Johannesbg); 2013 Jan; 16(1):45-9. PubMed ID: 23417636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis
    Voce A; Calabria B; Burns R; Castle D; McKetin R
    Subst Use Misuse; 2019; 54(4):549-559. PubMed ID: 30693832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.